Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
Authors:
Top Cited Papers
- 1 June 2019
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (6) , 539-548
Abstract
No abstract availableKeywords
Funding Information
- Mitsubishi Tanabe Pharma Corporation
- Boehringer Ingelheim
- Daiichi Sankyo Company
- National Institute of Neurological Disorders and Stroke
- Otsuka Pharmaceutical
- Dainippon Sumitomo Pharma
- Shionogi
- AstraZeneca
- National Institutes of Health
- Takeda Pharmaceutical Company
- Bayer
- Otsuka Pharmaceutical
- Sanofi
- Bristol-Myers Squibb
This publication has 31 references indexed in Scilit:
- Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: A meta-analysis of randomized controlled trialsInternational Journal of Cardiology, 2013
- Risk Score for Predicting Recurrence in Patients with Ischemic Stroke: The Fukuoka Stroke Risk Score for JapaneseCerebrovascular Diseases, 2012
- Antiplatelet DrugsChest, 2012
- Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke ModelStroke, 2012
- Efficacy and Safety of Combination Antiplatelet Therapies in Patients With Symptomatic Intracranial Atherosclerotic StenosisStroke, 2011
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeNew England Journal of Medicine, 2008
- Clopidogrel for the secondary prevention of strokeExpert Opinion on Pharmacotherapy, 2005
- Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial StenosisStroke, 2005
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993